E-LIB Suche - Ergebnisse für: Redekop, W. Ken

1

Radiology AI Deployment and Assessment Rubric (RADAR) to br..:

Boverhof, Bart-Jan ; Redekop, W. Ken ; Bos, Daniel...
Insights into Imaging. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Broadening the HTA of medical AI: A review of the literatur..:

Boverhof, Bart-Jan ; Redekop, W. Ken ; Visser, Jacob J...
Health Policy and Technology. 13 (2024) 2 - p. 100868 , 2024

Link: https://doi.org/10.1016/..

3

Incorporating risk preferences of patients in the valuation..:

Zaim, Remziye ; Redekop, W. Ken ; Uyl-de Groot, Carin A.
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Cost-effectiveness of first line nivolumab-ipilimumab combi..:

Zaim, Remziye ; Redekop, W. Ken ; Uyl-de Groot, Carin A.
Frontiers in Health Services. 3 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

5

Long-Term Effects of Dexmedetomidine versus Propofol During..:

ter Bruggen, Feline FJA ; Redekop, W Ken ; Stronks, Dirk L.
Journal of Pain Research. 14 (2021) - p. 3631-3636 , 2021

Link: https://doi.org/10.2147/..

6

A Systematic Review of Cost-Effectiveness Studies of Interv..:

Galekop, Milanne M.J. ; Uyl-de Groot, Carin A. ; Ken Redekop, W.
Value in Health. 24 (2021) 3 - p. 325-335 , 2021

Link: https://doi.org/10.1016/..

7

Future of Data Analytics in the Era of the General Data Pro..:

Kolasa, Katarzyna ; Ken Redekop, W. ; Berler, Alexander..
PharmacoEconomics. 38 (2020) 10 - p. 1021-1029 , 2020

Link: https://doi.org/10.1007/..

8

European cooperation on healthcare: report on the FPM-HPT c..:

Singer, Donald R.J. ; Bakker, Lytske J. ; Redekop, W. Ken
Health Policy and Technology. 8 (2019) 3 - p. 209-210 , 2019

Link: https://doi.org/10.1016/..

9

How can we make better decisions about the development and ..:

Redekop, W. Ken
Health Policy and Technology. 8 (2019) 1 - p. 3-4 , 2019

Link: https://doi.org/10.1016/..

10

In this issue: improving health outcomes and reducing healt..:

Redekop, W. Ken
Health Policy and Technology. 8 (2019) 3 - p. 207-208 , 2019

Link: https://doi.org/10.1016/..

11

Response to 'Comment on ''Adjuvant Trastuzumab Therapy for ..:

Ansaripour, Amir ; Uyl-de Groot, Carin A. ; Redekop, W. Ken
PharmacoEconomics. 36 (2018) 3 - p. 381-382 , 2018

Link: https://doi.org/10.1007/..

12

Use of data-mining to support real-world cost analyses: An ..:

Ansaripour, Amir ; Zendehdel, Kazem ; Tadayon, Niki...
PLOS ONE. 13 (2018) 10 - p. e0205079 , 2018

Link: https://doi.org/10.1371/..

13

International differences in patient access to ultra-orphan..:

Kanters, Tim A. ; Redekop, W. Ken ; Hakkaart, Leona
Health Policy and Technology. 7 (2018) 1 - p. 57-64 , 2018

Link: https://doi.org/10.1016/..

14

Fake news, big data, and the opportunities and threats of t..:

Redekop, W. Ken
Health Policy and Technology. 7 (2018) 2 - p. 113-114 , 2018

Link: https://doi.org/10.1016/..

15

Healthcare problems cannot be solved using health technolog..:

Redekop, W. Ken ; Bakker, Lytske J. ; Aarts, Jos
Health Policy and Technology. 7 (2018) 1 - p. 3-4 , 2018

Link: https://doi.org/10.1016/..